155 related articles for article (PubMed ID: 9582530)
1. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.
Heine B; Hummel M; Müller M; Heicappell R; Miller K; Stein H
J Pathol; 1998 Jan; 184(1):71-6. PubMed ID: 9582530
[TBL] [Abstract][Full Text] [Related]
2. [Telomerase activity as marker of superficial tumor of the bladder].
Arias Fúnez F; Fernández Fernández E; Escudero Barrilero A; Moyano Jato A; Caso Peláez E
Arch Esp Urol; 2000 Apr; 53(3):231-6. PubMed ID: 10851728
[TBL] [Abstract][Full Text] [Related]
3. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.
Gelmini S; Crisci A; Salvadori B; Pazzagli M; Selli C; Orlando C
Clin Cancer Res; 2000 Jul; 6(7):2771-6. PubMed ID: 10914723
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer.
Dettlaff-Pokora A; Matuszewski M; Schlichtholz B
Cancer Lett; 2005 May; 222(1):83-8. PubMed ID: 15837544
[TBL] [Abstract][Full Text] [Related]
5. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
Bian W; Xu Z
Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565
[TBL] [Abstract][Full Text] [Related]
6. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Lee DH; Yang SC; Hong SJ; Chung BH; Kim IY
Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
[TBL] [Abstract][Full Text] [Related]
9. Urine telomerase activity for the detection of bladder cancer in females.
Bravaccini S; Sanchini MA; Granato AM; Gunelli R; Nanni O; Amadori D; Calistri D; Silvestrini R
J Urol; 2007 Jul; 178(1):57-61. PubMed ID: 17574060
[TBL] [Abstract][Full Text] [Related]
10. Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer.
Müller M; Krause H; Heicappell R; Tischendorf J; Shay JW; Miller K
Clin Cancer Res; 1998 Aug; 4(8):1949-54. PubMed ID: 9717824
[TBL] [Abstract][Full Text] [Related]
11. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.
Siracusano S; Niccolini B; Knez R; Tiberio A; Benedetti E; Bonin S; Ciciliato S; Pappagallo GL; Belgrano E; Stanta G
Eur Urol; 2005 Mar; 47(3):327-33. PubMed ID: 15716196
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise.
Cassel A; Rahat MA; Lahat N; Lindenfeld N; Mecz Y; Stein A
J Urol; 2001 Sep; 166(3):841-4. PubMed ID: 11490230
[TBL] [Abstract][Full Text] [Related]
13. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer.
Eissa S; Swellam M; Ali-Labib R; Mansour A; El-Malt O; Tash FM
J Urol; 2007 Sep; 178(3 Pt 1):1068-72. PubMed ID: 17644139
[TBL] [Abstract][Full Text] [Related]
14. Comparison of screening methods in the detection of bladder cancer.
Ramakumar S; Bhuiyan J; Besse JA; Roberts SG; Wollan PC; Blute ML; O'Kane DJ
J Urol; 1999 Feb; 161(2):388-94. PubMed ID: 9915409
[TBL] [Abstract][Full Text] [Related]
15. [Telomerase activity: a molecular marker for early diagnosis of bladder tumor].
Calistri D; Sanchini A; Amadori D; Silvestrini R
Recenti Prog Med; 2007 Feb; 98(2):74-8. PubMed ID: 17439065
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity in patients with transitional cell carcinoma: a preliminary study.
Rahat MA; Lahat N; Gazawi H; Resnick MB; Sova Y; Ben-Ari G; Cohen M; Stein A
Cancer; 1999 Feb; 85(4):919-24. PubMed ID: 10091771
[TBL] [Abstract][Full Text] [Related]
17. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
18. Telomerase and other novel approaches to bladder cancer detection.
Bennett A
Clin Lab Sci; 2008; 21(3):185-90; quiz 191-2, following 192. PubMed ID: 18678141
[TBL] [Abstract][Full Text] [Related]
19. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.
Ito H; Kyo S; Kanaya T; Takakura M; Koshida K; Namiki M; Inoue M
Clin Cancer Res; 1998 Nov; 4(11):2807-10. PubMed ID: 9829746
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity is correlated with lower grade and lower stage bladder carcinomas.
Okumura A; Mizuno I; Nagakawa O; Fuse H
Int J Urol; 2004 Dec; 11(12):1082-6. PubMed ID: 15663679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
